[PDF] 18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer | Semantic Scholar Skip to search formSkip to main content> Semantic Scholar's Logo Search Sign InCreate Free Account You are currently offline. Some features of the site may not work correctly. DOI:10.2967/jnumed.115.157875 Corpus ID: 357655318F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer @article{Avril201618FFDGPF, title={18F-FDG PET/CT for Monitoring of Treatment Response in Breast Cancer}, author={S. Avril and R. Muzic and D. Plecha and B. Traughber and S. Vinayak and N. Avril}, journal={The Journal of Nuclear Medicine}, year={2016}, volume={57}, pages={34S - 39S} } S. Avril, R. Muzic, +3 authors N. Avril Published 2016 Medicine The Journal of Nuclear Medicine Changes in tumor metabolic activity have been shown to be an early indicator of treatment effectiveness for breast cancer, mainly in the neoadjuvant setting. The histopathologic response at the completion of chemotherapy has been used as the reference standard for assessment of the accuracy of 18F-FDG PET in predicting a response during systemic treatment. Although a pathologic complete response (pCR) remains an important positive prognostic factor for an individual patient, a recent… Expand View on Publisher jnm.snmjournals.org Save to Library Create Alert Cite Launch Research Feed Share This Paper 55 CitationsBackground Citations 9 Methods Citations 5 Results Citations 1 View All Figures, Tables, and Topics from this paper figure 1 table 1 figure 2 Fluorodeoxyglucose F18 Mammary Neoplasms Functional discourse grammar Neoadjuvant Therapy Radiology Pet Therapy Triple Negative Breast Neoplasms Prognostic Factors Subtype (attribute) Stratification systemic therapy Histopathology Polymerase Chain Reaction Pituitary Neoplasms Large Malignant neoplasm of breast Hospitals, Voluntary pediatric intracranial germ cell brain tumor Reference Standards 55 Citations Citation Type Citation Type All Types Cites Results Cites Methods Cites Background Has PDF Publication Type Author More Filters More Filters Filters Sort by Relevance Sort by Most Influenced Papers Sort by Citation Count Sort by Recency Current Landscape of Breast Cancer Imaging and Potential Quantitative Imaging Markers of Response in ER-Positive Breast Cancers Treated with Neoadjuvant Therapy E. Jones, Deep K Hathi, +6 authors N. Hylton Medicine Cancers 2020 2 PDF View 1 excerpt, cites methods Save Alert Research Feed Additional value of 18F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer Mette S. van Ramshorst, S. C. Teixeira, +9 authors M. V. Vrancken Peeters Medicine Cancer Imaging 2017 PDF Save Alert Research Feed Integrated 18F-FDG PET/MRI in breast cancer: early prediction of response to neoadjuvant chemotherapy N. Cho, S. Im, +8 authors K. J. Suh Medicine European Journal of Nuclear Medicine and Molecular Imaging 2017 14 View 2 excerpts, cites background Save Alert Research Feed GlucoCEST MRI for the early evaluation response to chemotherapeutic and metabolic treatments in a murine triple negative breast cancer: a comparison with [18F]F-FDG-PET Martina Capozza, Annasofia Anemone, +7 authors S. Aime Biology 2021 PDF Save Alert Research Feed Update on Quantitative Imaging for Predicting and Assessing Response in Oncology. Jennifer A Gillman, A. Pantel, D. Mankoff, Christine E. Edmonds Medicine Seminars in nuclear medicine 2020 Save Alert Research Feed Combination of breast imaging parameters obtained from 18F-FDG PET and CT scan can improve the prediction of breast-conserving surgery after neoadjuvant chemotherapy in luminal/HER2-negative breast cancer. M. Grapin, C. Coutant, +4 authors O. Humbert Medicine European journal of radiology 2019 3 Save Alert Research Feed Quantitative Evaluation of Therapeutic Response by FDG-PET–CT in Metastatic Breast Cancer D. Goulon, H. Necib, Brice Henaff, C. Rousseau, T. Carlier, F. Kraeber-Bodéré Medicine Front. Med. 2016 6 View 2 excerpts, cites background Save Alert Research Feed Response evaluation with 18F-FDG PET/CT in metastatic breast cancer patients treated with Palbociclib: first experience in clinical practice S. Taralli, M. Lorusso, V. Scolozzi, V. Masiello, F. Marazzi, M. Calcagni Medicine Annals of Nuclear Medicine 2018 2 Save Alert Research Feed Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in 18F-FDG-PET/CT Imaging for Predicting Pathological Complete Response in Breast Cancers Treated with Preoperative Chemotherapy Tomoko Higuchi, Yukie Fujimoto, +7 authors Y. Miyoshi Medicine Annals of Surgical Oncology 2019 4 PDF View 1 excerpt, cites background Save Alert Research Feed Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers G. Ulaner, D. Goldman, +4 authors M. Dickler Medicine The Journal of Nuclear Medicine 2017 20 PDF Save Alert Research Feed ... 1 2 3 4 5 ... References SHOWING 1-10 OF 54 REFERENCES SORT BYRelevance Most Influenced Papers Recency Response to Therapy in Breast Cancer N. Avril, S. Sassen, R. Roylance Medicine Journal of Nuclear Medicine 2009 92 PDF View 1 excerpt, references background Save Alert Research Feed Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J. Dose Schwarz, M. Bader, L. Jenicke, G. Hemminger, F. Jänicke, N. Avril Medicine Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005 216 PDF View 1 excerpt, references background Save Alert Research Feed Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using 18F-FDG PET in luminal HER2-negative breast cancer O. Humbert, A. Berriolo-Riedinger, +9 authors F. Brunotte Medicine European Journal of Nuclear Medicine and Molecular Imaging 2013 48 Save Alert Research Feed Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study N. Mortazavi-Jehanno, Anne-Laure Giraudet, +7 authors J. Albérini Medicine European Journal of Nuclear Medicine and Molecular Imaging 2011 42 View 1 excerpt, references background Save Alert Research Feed Glycolytic activity with 18F-FDG PET/CT predicts final neoadjuvant chemotherapy response in breast cancer A. Vicente, M. C. Mora, +6 authors Á. Castrejón Medicine Tumor Biology 2014 17 Save Alert Research Feed Is 18F-FDG PET accurate to predict neoadjuvant therapy response in breast cancer? A meta-analysis Y. Wang, C. Zhang, J. Liu, G. Huang Medicine Breast Cancer Research and Treatment 2011 111 View 2 excerpts, references methods and background Save Alert Research Feed HER2-positive breast cancer: 18F-FDG PET for early prediction of response to trastuzumab plus taxane-based neoadjuvant chemotherapy O. Humbert, A. Cochet, +10 authors F. Brunotte Medicine European Journal of Nuclear Medicine and Molecular Imaging 2014 49 View 1 excerpt, references background Save Alert Research Feed Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+/HER2− Breast Cancer D. Groheux, A. Sanna, +10 authors E. Hindie Medicine The Journal of Nuclear Medicine 2015 29 PDF View 1 excerpt, references background Save Alert Research Feed Changes in 18F-FDG tumor metabolism after a first course of neoadjuvant chemotherapy in breast cancer: influence of tumor subtypes. O. Humbert, A. Berriolo-Riedinger, +6 authors F. Brunotte Medicine Annals of oncology : official journal of the European Society for Medical Oncology 2012 82 Save Alert Research Feed Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer M. Schelling, N. Avril, +8 authors M. Schwaiger Medicine 2000 464 View 2 excerpts, references results Save Alert Research Feed ... 1 2 3 4 5 ... Related Papers Abstract Figures, Tables, and Topics 55 Citations 54 References Related Papers Stay Connected With Semantic Scholar Sign Up About Semantic Scholar Semantic Scholar is a free, AI-powered research tool for scientific literature, based at the Allen Institute for AI. Learn More → Resources DatasetsSupp.aiAPIOpen Corpus Organization About UsResearchPublishing PartnersData Partners   FAQContact Proudly built by AI2 with the help of our Collaborators Terms of Service•Privacy Policy The Allen Institute for AI By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License ACCEPT & CONTINUE